Rebecca D. Considine Research Institute (@achresearch) 's Twitter Profile
Rebecca D. Considine Research Institute

@achresearch

The catalyst for research and innovation at @AkronChildrens. Focused on developing new medicines, therapies, devices & procedures to improve the health of kids.

ID: 1039951960282198017

linkhttp://www.akronchildrens.org/research calendar_today12-09-2018 19:00:43

259 Tweet

178 Followers

216 Following

Rebecca D. Considine Research Institute (@achresearch) 's Twitter Profile Photo

Congratulations to Daniel Grossoehme for winning Best in Category for his poster, “Integrating Palliative Care into Burn Care: A Retrospective Application of Criteria for Appropriate Referral”!

Congratulations to Daniel Grossoehme for winning Best in Category for his poster, “Integrating Palliative Care into Burn Care: A Retrospective Application of Criteria for Appropriate Referral”!
Rebecca D. Considine Research Institute (@achresearch) 's Twitter Profile Photo

A sincere THANK YOU to the Hower Family and this latest gift from Mr. James H Hower! Your transformational gift enables us to live out our mission of elevating child health through discovery and innovation. Thank you for choosing to invest in pediatric research & innovation!

Rebecca D. Considine Research Institute (@achresearch) 's Twitter Profile Photo

A few of the study team for the Dupixent (dupilumab) study at Akron Children’s Hospital got together to celebrate enrolling the first patient. This study is the first for testing Dupixent for use to relieve itching in burn patients that have received skin grafts for their burns.

A few of the study team for the Dupixent (dupilumab) study at Akron Children’s Hospital got together to celebrate enrolling the first patient. This study is the first for testing Dupixent for use to relieve itching in burn patients that have received skin grafts for their burns.